MedicalResearch.com eInterview with Vincent Yi-Fong Su MD Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan MedicalResearch.com: What are the main findings of the study? Answer: Amiodarone, one of the most widely used medications to treat arrhythmias may increase the risk of developing cancer, especially in men and people exposed to high amounts of the drug. That is the conclusion of a new retrospective study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. Patients who were male or who received high cumulative daily doses of amiodarone within the first year had an increased risk of developing cancer. Those with both factors were 46 percent more likely to develop cancer than those with neither factor. (more…)